DTP Vaccines Global Market Opportunities And Strategies To 2031

DTP Vaccines Global Market Opportunities And Strategies To 2031

DTP Vaccines Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global DTP Vaccines market as it emerges from the COVID 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:

Where is the largest and fastest growing market for DTP Vaccines? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The DTP Vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider DTP Vaccines market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about DTP vaccines market.
  • Key Trends
Highlights the major trends shaping the global DTP vaccines market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth
Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis
Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country.
  • Market Segmentation
Contains the market values (2016-2031) and analysis for for segment by product type, by disease, and by end user in the market.
  • Regional Market Size and Growth
Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations
This section Includes recommendations for DTP vaccines providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Scope

Markets Covered:

1) By Product type: DTaP; TD; Tdap

2) By Disease: Diphtheria; Pertussis; Tetanus

3) By End-User: Hospitals; Clinics; Vaccination Centers

Companies Mentioned: GlaxoSmithKline; Sanofi; Merck & Co. Inc.; Meiji Holdings Co., Ltd.; Shenzhen Kangtai Biological Products; Serum Institute of India Pvt. Ltd.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; DTP Vaccines indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. DTP Vaccines Market Definition and Segmentations
6.4. Market Segmentation By Product Type
6.4.1. DTaP
6.4.2. TD
6.4.3. Tdap
6.5. Market Segmentation By Disease
6.5.1. Diphtheria
6.5.2. Pertussis
6.5.3. Tetanus
6.6. Market Segmentation By End User
6.6.1. Hospitals
6.6.2. Clinics
6.6.3. Vaccination Centers
7. Major Market Trends
7.1. Development Of Combination Vaccines
7.2. Strategic Acquisitions
7.3. Robust Research And Development
7.4. Artificial Intelligence In Vaccine Development
8. Global Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, 2016 – 2021, Value ($ Million)
8.2.1. Market Drivers 2016 – 2021
8.2.2. Market Restraints 2016 – 2021
8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
8.3.1. Market Drivers 2021 – 2026
8.3.2. Market Restraints 2021 – 2026
9. Global Market Segmentation
9.1. Global DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.2. Global DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
9.3. Global DTP Vaccines Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis
10.1. Global DTP Vaccines Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10.2. Global DTP Vaccines Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes Levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.4. Asia-Pacific DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.5. Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.6. Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.7. Asia-Pacific DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.8. Asia Pacific DTP Vaccines Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes Levied
11.11.9. Corporate Tax Structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.13. China DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.14. China DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.15. China DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.16. China DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.17. India Market
11.18. India DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.19. India DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.20. India DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.21. India DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.22. India DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.23. Japan Market
11.24. Japan DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.25. Japan DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.26. Japan DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.27. Japan DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.28. Japan DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Market
11.30. Australia DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.31. Australia DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.32. Australia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.33. Australia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.34. Australia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.37. Indonesia DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.38. Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.39. Indonesia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.40. Indonesia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
11.43. South Korea DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
11.44. South Korea DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.45. South Korea DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11.46. South Korea DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes Levied
12.2.9. Corporate Tax Structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.4. Western Europe DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.5. Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.8. Western Europe DTP Vaccines Market: Country Analysis
12.9. UK Market
12.10. UK DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.11. UK DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.12. UK DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.13. UK DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.14. UK DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.15. Germany Market
12.16. Germany DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.17. Germany DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.18. Germany DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.19. Germany DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.20. Germany DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.21. France Market
12.22. France DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
12.23. France DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
12.24. France DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.25. France DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12.26. France DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulations
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.4. Eastern Europe DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.5. Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.8. Eastern Europe DTP Vaccines Market: Country Analysis
13.9. Russia Market
13.10. Russia DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
13.11. Russia DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
13.12. Russia DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.13. Russia DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13.14. Russia DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate tax structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.4. North America DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.5. North America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.6. North America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.7. North America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.8. North America DTP Vaccines Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes Levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
14.13. USA DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
14.14. USA DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.15. USA DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14.16. USA DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.4. South America DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.5. South America DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.6. South America DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.7. South America DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.8. South America DTP Vaccines Market: Country Analysis
15.9. Brazil Market
15.10. Brazil DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
15.11. Brazil DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
15.12. Brazil DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.13. Brazil DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15.14. Brazil DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
16.4. Middle East DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
16.5. Middle East DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16.7. Middle East DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa DTP Vaccines Market, Historic Market Growth, 2016 – 2021, Value ($ Million)
17.4. Africa DTP Vaccines Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million)
17.5. Africa DTP Vaccines Market, Segmentation By Product Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa DTP Vaccines Market, Segmentation By Disease, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17.7. Africa DTP Vaccines Market, Segmentation End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape And Company Profiles
18.1. Company Profiles
18.2. GlaxoSmithKline plc
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. Sanofi SA
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Merck & Co. Inc.
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. Meiji Holdings Co., Ltd
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Shenzhen Kangtai Biological Products
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. DTP Vaccines Pipeline Analysis
20. Key Mergers And Acquisitions
20.1. Sanofi S.A. Acquired Kymab Ltd
20.2. Merck & Co Acquired Pandion Therapeutics
20.3. Novartis AG Acquired The Medicines Company
20.4. BioNTech SE Acquired GMP Certified Manufacturing Site Of Novartis AG
20.5. Sanofi SA Acquired Synthrox
20.6. Bharat Biotech International Limited Acquired Chiron Behring Vaccines From GlaxoSmithKline
20.7. Bavarian Nordic A/S Acquired Global Rights For Two Vaccines from GSK
21. Future Outlook and Potential Analysis
21.1. Global DTP Vaccines Market In 2026 – Countries Offering Most New Opportunities
21.2. Global DTP Vaccines Market In 2026 – Segments Offering Most New Opportunities
21.3. Global DTP Vaccines Market In 2026 – Growth Strategies
21.3.1. Market Trend Based Strategies
21.3.2. Competitor Strategies
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. The Business Research Company
23. Copyright and Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings